Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Somatic gene therapy.

C Hesdorffer1, D Markowitz, M Ward

  • 1Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York.

Hematology/Oncology Clinics of North America
|June 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation of DNA test for hip dysplasia failed in Danish Labrador Retrievers.

Animal genetics·2020
Same author

Transfer and expression of the human multiple drug resistance gene as potential human gene therapy.

Cytotechnology·2012
Same author

Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer.

British journal of cancer·2011
Same author

Excess alpha chain synthesis relative to beta chain synthesis in thalassaemia major and minor.

Nature·2010
Same author

The effects of l-cycloserine on gangliosides in the developing mouse brain.

Neurochemistry international·2010
Same author

The role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression.

Oncogene·2009
Same journal

Palliative Therapy for Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Ablative Therapies for Liver Tumors.

Hematology/oncology clinics of North America·2026
Same journal

Pathology of Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery for Liver and Biliary Tract Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Surgical Considerations for Primary Liver Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Systemic Therapy for Biliary and Liver Neoplasms: Chemotherapy and Immunotherapy.

Hematology/oncology clinics of North America·2026
See all related articles

Improving gene transfer into hematopoietic stem cells requires higher viral titers and optimized growth factor combinations. Further research is needed to enhance stem cell transplantation for treating genetic blood disorders.

Area of Science:

  • Hematology
  • Gene Therapy
  • Molecular Biology

Background:

  • Retroviral gene transfer into hematopoietic stem cells faces challenges with efficiency and long-term expression, particularly for regulated genes like human beta globin.
  • Key issues include insufficient stem cell infection rates and potential conflicts between gene sequences and viral replication cycles, hindering successful gene therapy.

Purpose of the Study:

  • To identify strategies for improving the efficiency of retroviral gene transfer into hematopoietic stem cells.
  • To explore methods for increasing viral titer and optimizing stem cell proliferation for enhanced gene delivery.

Main Methods:

  • Investigating the transfect/infect method for increasing viral production.
  • Evaluating the efficacy of single and combination growth factors, including interleukin-3, interleukin-6, interleukin-1, and granulocyte-macrophage colony-stimulating factor (GM-CSF), to promote stem cell cycling.

Related Experiment Videos

  • Exploring long-term bone marrow and stromal cell cultures for improved stem cell maintenance and expansion.

    • Main Results:

    • The transfect/infect method shows promise for increasing viral titer.
    • Interleukin-3 appears to be the most effective single growth factor, with combinations like interleukin-3 plus interleukin-6 demonstrating potential for enhancing stem cell proliferation.
    • Optimizing culture conditions and stem cell numbers is crucial for successful transplantation.

    Conclusions:

    • Enhancing viral titer and utilizing specific growth factor combinations are critical for successful gene transfer into hematopoietic stem cells.
    • Further advancements in gene transfer efficiency, gene expression, and stem cell culture are necessary before clinical application for hematologic genetic diseases.